Ageing, telomeres, senescence, and liver injury

Slides:



Advertisements
Similar presentations
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
Advertisements

Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
1 H2AX: functional roles and potential applications.
 Background information › PTEN (function, connection with breast cancer)  Objective  Experimental Approach and Results  Conclusion  Future research.
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Cellular Senescence What is it? What causes it? Why is it important
Targets of Immune Regeneration in Rheumatoid Arthritis
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Senescence/SASP...
Volume 14, Issue 4, Pages (May 2004)
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Pathways of liver injury in alcoholic liver disease
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Volume 41, Issue 6, Pages (December 2004)
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Gianluca Tell, Carlo Vascotto, Claudio Tiribelli  Journal of Hepatology 
Volume 47, Issue 1, Pages (July 2007)
Camptothecin‐induced DNA damage response is ataxia telangiectasia mutated dependent in post‐mitotic cells. Camptothecin‐induced DNA damage response is.
Induction of DNA double‐strand breaks and activation of the ataxia telangiectasia mutated pathway in post‐mitotic cells in response to camptothecin. Induction.
Volume 57, Issue 5, Pages (November 2012)
Fatty Acid-Induced T Cell Loss Greases Liver Carcinogenesis
Florie Borel, Pavlina Konstantinova, Peter L.M. Jansen 
Targets of Immune Regeneration in Rheumatoid Arthritis
Is Hepatitis C Virus Carcinogenic?
Volume 56, Issue 3, Pages (March 2012)
Endoplasmic reticulum stress in liver disease
Targets of Immune Regeneration in Rheumatoid Arthritis
Volume 64, Issue 1, Pages (January 2016)
Volume 64, Issue 5, Pages (May 2016)
Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma  André Lechel, Michael P. Manns, K.Lenhard Rudolph 
Hepatitis C core protein – The “core” of immune deception?
Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions  Garrick K. Wilson, Daniel A. Tennant,
Signalling pathways in alcohol-induced liver inflammation
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Daniel J. Felmlee, Thomas F. Baumert  Journal of Hepatology 
Pathways of liver injury in alcoholic liver disease
JNK mediates hepatic ischemia reperfusion injury
Volume 61, Issue 6, Pages (December 2014)
Therapeutic editing of hepatocyte genome in vivo
Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age- Related Phenotypes through Telomerase Manipulation  Elsa Vera, Nazario.
Barbara A. Gilchrest, Mark S. Eller 
Matthew J. Deeths, Bart T. Endrizzi, Michelle L. Irvin, Lynne P
Volume 59, Issue 5, Pages (September 2015)
Michael H Lam, Qinghua Liu, Stephen J Elledge, Jeffrey M Rosen 
Immunology of the healthy liver: Old questions and new insights
Volume 130, Issue 5, Pages (September 2007)
Volume 53, Issue 2, Pages (August 2010)
Volume 132, Issue 4, Pages (April 2007)
Volume 128, Issue 1, Pages (January 2005)
Cannabinoid signaling and liver therapeutics
Senescence in chronic liver disease: Is the future in aging?
Volume 59, Issue 2, Pages (August 2013)
DNA Double-Strand Breaks Come into Focus
NASH animal models: Are we there yet?
Volume 56, Issue 6, Pages (June 2012)
Volume 44, Issue 5, Pages (May 2006)
Switching and Signaling at the Telomere
Graeme Hewitt, Viktor I. Korolchuk  Trends in Cell Biology 
DNA Damage Foci at Dysfunctional Telomeres
Volume 58, Issue 5, Pages (May 2013)
ATM function in repair of double-stranded DNA breaks.
Kanad Ghosh, Brian C. Capell  Journal of Investigative Dermatology 
Genetics of hepatocellular carcinoma: The next generation
Are Mouse Telomeres Going to Pot?
Nathalie Ganne-Carrié, Pierre Nahon  Journal of Hepatology 
Volume 13, Issue 1, Pages (October 2015)
Presentation transcript:

Ageing, telomeres, senescence, and liver injury Matthew Hoare, Tapas Das, Graeme Alexander  Journal of Hepatology  Volume 53, Issue 5, Pages 950-961 (November 2010) DOI: 10.1016/j.jhep.2010.06.009 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Eos and Tithonus. The Goddess Eos abducting the Trojan Tithonus in his youth portrayed traditionally holding a lyre. Journal of Hepatology 2010 53, 950-961DOI: (10.1016/j.jhep.2010.06.009) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Age-related changes seen on liver biopsy specimens include accumulation of lipofuscin (A–C) and large cell change (D). Liver biopsy specimen taken from a 72year-old male with NAFLD stained with (A) haematoxylin and Eosin (H&E), diastase periodic-acid Schiff (dPAS) (B) and Chromotrope Aniline Blue (CAB) stain demonstrating intra-cytoplasmic granules of lipofuscin (arrow heads) adjacent to an hepatic venule (v) confirmed as dPAS resistant (B) but negative on the CAB stain (C). (D) Large cell change from the same biopsy specimen (arrow). Images were taken at 40× magnification, courtesy of Dr. Susan Davies. Journal of Hepatology 2010 53, 950-961DOI: (10.1016/j.jhep.2010.06.009) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Causes and consequences of cellular senescence. Cellular senescence can be caused by a number of cellular stresses including telomere dysfunction. Other causes include oxidative stress, non-telomeric DNA damage, and oncogenic activation. Cellular senescence is characterised by cell-cycle arrest, resistance to apoptosis, epigenetic changes including formation of senescence-associated heterochromatic foci, and the senescence-associated secretory phenotype. Journal of Hepatology 2010 53, 950-961DOI: (10.1016/j.jhep.2010.06.009) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Telomere analysis by in situ hybridisation. (A–C) Examples of experimental methodologies demonstrating telomeres in human CD4+ lymphocytes by flow cytometric FISH, and (D) hepatocytes by quantitative FISH. Fresh human PBMCs are stained for CD4 and then a fluorochrome-labelled telomere consensus sequence is hybridised. Cells are then analysed in a flow-cytometer, gating on live lymphocytes (A), CD4+ lymphocytes (B), and then telomere length can be inferred from the mean fluorescence intensity (C). Paraffin-embedded liver biopsy tissue from a subject with NAFLD was stained with the hepatocyte-specific antibody Hep Par-1 (Green), nuclear stain DAPI (blue), and fluorochrome-labelled telomere consensus sequence (red) allowing study of telomeres in single cells or cellular populations. (Image courtesy of Dr. Aloysius Aravinthan). Journal of Hepatology 2010 53, 950-961DOI: (10.1016/j.jhep.2010.06.009) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 5 Structure of mammalian telomeres. (A) The G-rich 3′ single-stranded overhang inserts into the upstream double-stranded telomeric DNA to form a protective t-loop configuration at the end of chromosomes. (B) Peri-telomeric shelterin complex contains six proteins in mammals: TRF1, TRF2, TIN2, RAP1, TPP1, and POT1. POT1 prevents the generation of a single-stranded DNA damage response by binding to the 3′ overhanging strand. Adapted from Cesare and Reddel, 2010 [136]. Journal of Hepatology 2010 53, 950-961DOI: (10.1016/j.jhep.2010.06.009) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 6 Short telomeres generate a double strand break (DSB) DNA damage response. Progressive telomere shortening is signalled to ATM/ATR by the MRN complex leading to phosphorylation of Histone 2 (H2) at serine 139 to form γ-H2AX (B). Generation of γ-H2AX leads to a positive feedback loop-inducing phosphorylation of further ATM/ATR. γ-H2AX also allows binding of other factors in the DSB response pathway including the mediator of DNA damage checkpoint protein 1 (MDC1) and p53 binding protein-1 (53BP1) [50] (C). Activation of ATM/ATR leads to downstream signalling through phosphorylation of the checkpoint kinases CHK1 and CHK2 leading to activation of p53 and arrest of further mitosis. Journal of Hepatology 2010 53, 950-961DOI: (10.1016/j.jhep.2010.06.009) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 7 Senescent cells develop the senescent-associated secretory phenotype (SASP). Senescent cells secrete large quantities of IL-6, IL-8, and plasminogen activator inhibitor-1 [133,137]. These can act in both an autocrine or paracrine manner to reinforce or induce senescence within cells. IL-6 acting via IL-6R/GP80 [133] or IL-8 acting via CXCR2 [137] act in concert with oncogenic stress to induce the senescent phenotype. ROS, reactive oxygen species. Journal of Hepatology 2010 53, 950-961DOI: (10.1016/j.jhep.2010.06.009) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions